Filing Details
- Accession Number:
- 0000899243-22-028291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-10 19:05:58
- Reporting Period:
- 2022-08-08
- Accepted Time:
- 2022-08-10 19:05:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1787400 | Nkarta Inc. | NKTX | Pharmaceutical Preparations (2834) | 474515206 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1853197 | Ralph Brandenberger | C/O Nkarta, Inc., 6000 Shoreline Court, Suite 102 South San Francisco CA 94080 | Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-08 | 4,367 | $0.41 | 12,167 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-08-08 | 6,886 | $3.89 | 19,053 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-08-08 | 340 | $4.77 | 19,393 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-08 | 11,593 | $15.51 | 7,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-08 | 4,367 | $0.00 | 4,367 | $0.41 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-08 | 6,886 | $0.00 | 6,886 | $3.89 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-08 | 340 | $0.00 | 340 | $4.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-07-18 | No | 4 | M | Direct | |
| 37,253 | 2029-09-05 | No | 4 | M | Direct | |
| 8,445 | 2029-05-10 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date.
- This transaction was executed in multiple trades at prices ranging from $15.00 to $16.00. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This stock option is fully vested.
- The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.
- The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.
Billionaire Hedge Funds
